Advertisement

Pain, Depression, and Anxiety in Cancer

  • Lora M. Thompson
  • Margarita Bobonis Babilonia
  • Sahana Rajasekhara
  • Kristine A. DonovanEmail author
Chapter

Abstract

The experience of pain is often associated with negative affect, such as anxiety and depression, and this relationship is evident in adult cancer patients, particularly those with advanced disease. Effective management of pain in cancer patients cannot be achieved without addressing co-occurring psychological factors (Portenoy 2011). The aim of this chapter is to summarize knowledge about depression and anxiety as they relate to pain in adult cancer patients. We will briefly review the etiology and prevalence of pain before summarizing the existing knowledge about the relationship of depression and anxiety to pain in adult cancer patients. We will then provide an overview of the etiology, methods of assessment, prevalence, and management of depression and anxiety as it pertains to adult cancer patients. Examples of studies conducted with cancer patients with pain and with palliative care patients will be discussed when relevant. Finally, we conclude with future directions for addressing depression and anxiety in cancer patients with pain.

References

  1. Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncol, 12, 612–619.CrossRefGoogle Scholar
  2. Akechi, T., Okuyama, T., Onishi, J., Morita, T., & Furukawa, T. A. (2008). Psychotherapy for depression among incurable cancer patients. Cochrane Database of Systematic Reviews, 2, CD005537.Google Scholar
  3. Akechi, T., Okuyama, T., Uchida, M., Nakaguchi, T., Sugano, K., Kubota, Y., et al. (2012). Clinical indicators of depression among ambulatory cancer patients undergoing chemotherapy. Japanese Journal of Clinical Oncology, 42(12), 1175–1180.PubMedCrossRefGoogle Scholar
  4. Allard, P., Maunsell, E., Labbe, J., & Dorval, M. (2001). Educational interventions to improve cancer pain control: A systematic review. Journal of Palliative Medicine, 4(2), 191–203.PubMedCrossRefGoogle Scholar
  5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, DC: American Psychiatric Pub.CrossRefGoogle Scholar
  6. Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., et al. (2014). Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. Journal of Clinical Oncology, 32(15), 1605–1619.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Andrew, B., Ng, C., & Jaafar, N. (2017). The use of methylphenidate in cancer patients: A review. Current Drug Targets, 19(8), 877–887.Google Scholar
  8. Andrisano, C., Chiesa, A., & Serretti, A. (2013). Newer antidepressants and panic disorder: A meta-analysis. International Clinical Psychopharmacology, 28(1), 33–45.PubMedCrossRefGoogle Scholar
  9. Arathuzik, D. (1994). Effects of cognitive-behavioral strategies on pain in cancer patients. Cancer Nursing, 17, 207–214.PubMedCrossRefGoogle Scholar
  10. Bakker, A., van Balkom, A. J., & Spinhoven, P. (2002). SSRIs vs. TCAs in the treatment of panic disorder: A meta-analysis. Acta Psychiatrica Scandinavica, 106(3), 163–167. doi: 2r255 [pii].Google Scholar
  11. Baldwin, D. S., Waldman, S., & Allgulander, C. (2011). Evidence-based pharmacological treatment of generalized anxiety disorder. International Journal of Neuropsychopharmacology, 14(5), 697–710.PubMedCrossRefGoogle Scholar
  12. Barsevick, A. M., Sweeney, C., Haney, E., & Chung, E. (2002). A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncology Nursing Forum, 29(1), 73–84; quiz 85-77.Google Scholar
  13. Beck, A. T., & Steer, R. A. (1990). Manual for the Beck anxiety inventory. San Antonio: Psychological Corporation.Google Scholar
  14. Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.Google Scholar
  15. Bennett, M. I., Bagnall, A.-M., & Closs, S. J. (2009). How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. PAIN®, 143(3), 192–199.CrossRefGoogle Scholar
  16. Berney, A., Stiefel, F., Mazzocato, C., & Buclin, T. (2000). Psychopharmacology in supportive care of cancer: A review for the clinician. III. Antidepressants. Support Care Cancer, 8(4), 278–286.PubMedGoogle Scholar
  17. Bishop, S. R., & Warr, D. (2003). Coping, catastrophizing and chronic pain in breast cancer. Journal of Behavioral Medicine, 26(3), 265–281.CrossRefGoogle Scholar
  18. Blake, D. D., Weathers, F., Nagi, L. M., Kaloupek, D. G., Klauminzer, G., Charney, D. S., & Keane, T. M. (1990). A clinician's rating scale for assessing current and lifetime PTSD: The CAPS 1. Behavior Therapist, 13, 187–188.Google Scholar
  19. Boettger, S., Jenewein, J., & Breitbart, W. (2015). Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. Palliative & Supportive Care, 13(4), 1079–1085.CrossRefGoogle Scholar
  20. Bottomley, A. (1998). Depression in cancer patients: A literature review. European Journal of Cancer Care, 7, 181–191.PubMedCrossRefGoogle Scholar
  21. Braun, I. M., & Pirl, W. F. (2010). Psychotropic medications in Cancer care. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, M. S. Lederberg, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (pp. 378–385). New York: Oxford University Press.CrossRefGoogle Scholar
  22. Bredal, I. S., Smeby, N. A., Ottesen, S., Warncke, T., & Schlichting, E. (2014). Chronic pain in breast cancer survivors: Comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. Journal of Pain and Symptom Management, 48(5), 852–862.CrossRefGoogle Scholar
  23. Breitbart, W., Rosenfeld, B., Pessin, H., Applebaum, A., Kulikowski, J., & Lichtenthal, W. G. (2015). Meaning-centered group psychotherapy: An effective intervention for improving psychological well-being in patients with advanced cancer. Journal of Clinical Oncology, 33(7), 749–754.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W., & Zabora, J. R. (2009). Mixed anxiety/depression symptoms in a large cancer cohort: Prevalence by cancer type. Psychosomatics, 50(4), 383–391.  https://doi.org/10.1176/appi.psy.50.4.383 50/4/383 [pii].CrossRefPubMedGoogle Scholar
  25. Brown, J. H., & Parakevas, F. (1982). Cancer and depression: Cancer presenting with depressive illness: An autoimmune disease? The British Journal of Psychiatry, 141, 227–232.PubMedCrossRefGoogle Scholar
  26. Bryant, R. A., Harvey, A. G., Dang, S. T., & Sackville, T. (1998). Assessing acute stress disorder: Psyshometric properties of a structured clinical interview. Psychological Assessment, 10, 215–220.CrossRefGoogle Scholar
  27. Buclin, T., Mazzocato, C., Berney, A., & Stiefel, F. (2001). Psychopharmacology in supportive care of cancer: A review for the clinician. IV. Other psychotropic agents. Support Care Cancer, 9(4), 213–222.PubMedCrossRefGoogle Scholar
  28. Buffart, L. M., Van Uffelen, J. G., Riphagen, I. I., Brug, J., van Mechelen, W., Brown, W. J., & Chinapaw, M. J. (2012). Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trials. BMC Cancer, 12(1), 559.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Bukberg, J., Penman, D., & Holland, J. C. (1984). Depression in hospitalized cancer patients. Psychosomatic Medicine, 46(3), 199–212.PubMedCrossRefGoogle Scholar
  30. Campeau, M.-P., Gaboriault, R., Drapeau, M., Van Nguyen, T., Roy, I., Fortin, B., et al. (2007). Impact of massage therapy on anxiety levels in patients undergoing radiation therapy: Randomized controlled trial. Journal of the Society for Integrative Oncology, 5(4).Google Scholar
  31. Cankurtaran, E. S., Ozalp, E., Soygur, H., Akbiyik, D. I., Turhan, L., & Alkis, N. (2008). Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: Superiority over imipramine. Supportive Care in Cancer, 16(11), 1291–1298.PubMedCrossRefGoogle Scholar
  32. Capuron, L., Ravaud, A., & Dantzer, R. (2000). Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. Journal of Clinical Oncology, 18(10), 2143–2151.PubMedCrossRefGoogle Scholar
  33. Capuron, L., Gumnick, J. F., Musselman, D. L., Lawson, D. H., Reemsnyder, A., Nemeroff, C. B., & Miller, A. H. (2002). Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 26, 643–652.PubMedCrossRefGoogle Scholar
  34. Carlson, L. E., Angen, M., Cullum, J., Goodey, E., Koopmans, J., Lamont, L., et al. (2004). High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer, 90(12), 2297–2304.  https://doi.org/10.1038/sj.bjc.6601887 6601887 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  35. Carr, D., Goudas, L., Lawrence, D., Pirl, W., Lau, J., DeVine, D., et al. (2002). Management of cancer symptoms: Pain, depression, and fatigue. Evidence Report/Technology Assessment No. 61. AHRQ Publication No. 02-E032. Rockville: Agency for Healthcare Research and Quality.Google Scholar
  36. Cassileth, B. R., Deng, G. E., Gomez, J. E., Johnstone, P. A., Kumar, N., & Vickers, A. J. (2007). Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 132(3 Suppl), 340S–354S.  https://doi.org/10.1378/chest.07-1389 132/3_suppl/340S [pii].CrossRefPubMedGoogle Scholar
  37. Chen, M.-L., Chang, H.-K., & Yeh, C.-H. (2000). Anxiety and depression in Taiwanese cancer patients with and without pain. Journal of Advanced Nursing, 32(4), 944–951.Google Scholar
  38. Cheung, Y. L., Molassiotis, A., & Chang, A. M. (2003). The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psycho-Oncol, 12, 254–266.CrossRefGoogle Scholar
  39. Chochinov, H. M., Wilson, K. G., Enns, M., & Lander, S. (1997). “Are you depressed?” screening for depression in the terminally ill. The American Journal of Psychiatry, 154(5), 674–676.PubMedCrossRefGoogle Scholar
  40. Ciaramella, A., & Poli, P. (2001). Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psychooncology, 10(2), 156–165.  https://doi.org/10.1002/pon.505 [pii].CrossRefPubMedGoogle Scholar
  41. Cleeland, C. S. (1984). The impact of pain on the patient with cancer. Cancer, 54(11 Suppl), 2635–2641.PubMedCrossRefGoogle Scholar
  42. Crane, R. (2017). Mindfulness-based cognitive therapy: Distinctive features. Routledge: Taylor & Francis.CrossRefGoogle Scholar
  43. Dahl, A. A., Haaland, C. F., Mykletun, A., Bremnes, R., Dahl, O., Klepp, O., et al. (2005). Study of anxiety disorder and depression in long-term survivors of testicular cancer. Journal of Clinical Oncology, 23, 2389–2395.  https://doi.org/10.1200/JCO.2005.05.061 23/10/2389 [pii].CrossRefPubMedGoogle Scholar
  44. Dalton, J. A., Keefe, F. J., Carlson, J., & Youngblood, R. (2004). Tailoring cognitive-behavioral treatment for cancer pain. Pain Management Nursing, 5(1), 3–18. doi: S1524904203000274 [pii].Google Scholar
  45. Deng, D., Fu, L., Zhao, Y. X., Wu, X., Zhang, G., Liang, C., et al. (2012). The relationship between cancer pain and quality of life in patients newly admitted to Wuhan hospice Center of China. American Journal of Hospice and Palliative Medicine®, 29(1), 53–59.CrossRefGoogle Scholar
  46. Derogatis, L. R., Morrow, G. R., Fetting, J., Penman, D., Piasetsky, S., Schmale, A. M., et al. (1983). The prevalence of psychiatric disorders among cancer patients. JAMA, 249(6), 751–757.PubMedCrossRefGoogle Scholar
  47. Devine, E. C. (2003). Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer. Oncology Nursing Forum, 30(1), 75–89.  https://doi.org/10.1188/03.ONF.75-89.CrossRefPubMedGoogle Scholar
  48. Devine, E. C., & Westlake, S. K. (1995). The effects of psychoeducational care provided to adults with cancer: Meta-analysis of 116 studies. Oncology Nursing Forum, 22, 1369–1381.PubMedGoogle Scholar
  49. DuHamel, K. N., Mosher, C. E., Winkel, G., Labay, L. E., Rini, C., Meschian, Y. M., et al. (2010). Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 28(23), 3754–3761.  https://doi.org/10.1200/JCO.2009.26.8722 JCO.2009.26.8722 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  50. Edelman, S., Bell, D. R., & Kidman, A. D. (1999). A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-Oncol, 8(4), 295–305.CrossRefGoogle Scholar
  51. Eli Lilly and Company. (2017). Cymbalta Medication Guide. From https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021427s049lbl.pdf
  52. Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., & Küffner, R. (2013). Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology, 31(6), 782–793.PubMedCrossRefGoogle Scholar
  53. Fallowfield, L., Ratcliffe, D., Jenkins, V., & Saul, J. (2001). Psychiatric morbidity and its recognition by doctors in patients with cancer. British Journal of Cancer, 84(8), 1011–1015.  https://doi.org/10.1054/bjoc.2001.1724 S0007092001917240 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  54. Feyer, P., & Jordan, K. (2010). Update and new trends in antiemetic therapy: The continuing need for novel therapies. Annals of Oncology.  https://doi.org/10.1093/annonc/mdq600 mdq600 [pii].PubMedCrossRefGoogle Scholar
  55. First, M. B., Gibbons, M., & Spitzer, R. L. (1996). Users guide for the structured clinical interview for DSM-IV axis I disorders: Research version. New York: Biometrics Research.Google Scholar
  56. Fischer, D. J., Villines, D., Kim, Y. O., Epstein, J. B., & Wilkie, D. J. (2010). Anxiety, depression, and pain: Differences by primary cancer. Support Care Cancer, 18(7), 801–810.  https://doi.org/10.1007/s00520-009-0712-5.CrossRefPubMedGoogle Scholar
  57. Fitzgibbon, D. (2010). Mechanisms, assessment, and diagnosis of pain due to cancer. In Bonica’s management of pain (pp. 559–582). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins.Google Scholar
  58. Glover, J., Dibble, S. L., Dodd, M. J., & Miaskowski, C. (1995). Mood states of oncology outpatients: Does pain make a difference? Journal of Pain and Symptom Management, 10(2), 120–128. doi: 088539249400073T [pii].Google Scholar
  59. Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345, 1719–1726.PubMedPubMedCentralCrossRefGoogle Scholar
  60. Greer, S., Moorey, S., Baruch, J. D., Watson, M., Robertson, B. M., Mason, A., et al. (1992). Adjuvant psychological therapy for patients with cancer: A prospective randomised trial. BMJ, 304, 675–680.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Greer, J. A., Traeger, L., Bemis, H., Solis, J., Hendriksen, E. S., Park, E. R., et al. (2012). A pilot randomized controlled trial of brief cognitive-behavioral therapy for anxiety in patients with terminal cancer. The Oncologist, 17(10), 1337–1345.PubMedPubMedCentralCrossRefGoogle Scholar
  62. Greer, J. A., MacDonal, J., & Traeger, L. (2015). Anxiety disorders. In J. C. Holland, W. S. Breitbart, P. N. Butow, P. B. Jacobsen, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (3rd ed., pp. 296–303). New York: Oxford University Press.Google Scholar
  63. Harter, M., Reuter, K., Aschenbrenner, A., Schretzmann, B., Marschner, N., Hasenburg, A., & Weis, J. (2001). Psychiatric disorders and associated factors in cancer: Results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. European Journal of Cancer, 37, 1385–1393.PubMedCrossRefGoogle Scholar
  64. Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., et al. (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 32(18), 1941–1967.PubMedCrossRefGoogle Scholar
  65. Holland, J. D., Korzun, A. H., Tross, S., Silberfarb, P., Perry, M., Comis, R., & Oster, M. (1986). Comparative psychological disturbance in patients with pancreatic and gastric cancer. The American Journal of Psychiatry, 143, 982–986.PubMedCrossRefGoogle Scholar
  66. Holland, J. C., Morrow, G. R., Schmale, A., Derogatis, L., Stefanek, M., Berenson, S., et al. (1991). A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. Journal of Clinical Oncology, 9, 1004–1011.PubMedCrossRefGoogle Scholar
  67. Holland, J. C., Romano, S. J., Heiligenstein, J. H., Tepner, R. G., & Wilson, M. G. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncol, 7(4), 291–300.CrossRefGoogle Scholar
  68. Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209–218.PubMedCrossRefGoogle Scholar
  69. Hotopf, M., Chidgey, J., Addington-Hall, J., & Ly, K. L. (2002). Depression in advanced disease: A systematic review part 1. Prevalence and case finding. Palliative Medicine, 16(2), 81–97.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Howell, D., Keshavarz, H., Esplen, M., Hack, T., Hamel, M., Howes, J., et al. (2015). A Pan Canadian practice guideline: Screening, assessment and care of psychosocial distress, depression, and anxiety in adults with cancer. Toronto: Canadian Partnership Against Cancer and the Canadian Association of Psychosocial Oncology.Google Scholar
  71. Hui, D., Frisbee-Hume, S., Wilson, A., Dibaj, S. S., Nguyen, T., De La Cruz, M., et al. (2017). Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: A randomized clinical trial. JAMA, 318(11), 1047–1056.PubMedPubMedCentralCrossRefGoogle Scholar
  72. Ipser, J. C., & Stein, D. J. (2012). Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). International Journal of Neuropsychopharmacology, 15(6), 825–840.PubMedCrossRefGoogle Scholar
  73. Jackson, K. C., & Lipman, A. G. (2004). Drug therapy for delirium in terminally ill patients. Cochrane Database of Systematic Reviews, 2, CD004770.  https://doi.org/10.1002/14651858.CD004770.CrossRefGoogle Scholar
  74. Jacobs, C., Ross, R. D., Walker, I. M., & Stockdale, F. E. (1983). Behavior of cancer patients: A randomized study of the effects of education and peer support groups. American Journal of Clinical Oncology, 6, 347–353.PubMedCrossRefGoogle Scholar
  75. Jacobsen, P. B., & Butler, R. W. (1996). Relation of cognitive coping and catastrophizing to acute pain and analgesic use following breast cancer surgery. Journal of Behavioral Medicine, 19(1), 17–29.PubMedCrossRefGoogle Scholar
  76. Jacobsen, P. B., & Donovan, K. A. (2015). Assessment and screening for anxiety and depression. In J. C. Holland, W. S. Breitbart, P. N. Butow, P. B. Jacobsen, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology. New York: Oxford University Press.Google Scholar
  77. Jacobsen, P. B., Donovan, K. A., Swaine, Z. N., & Watson, I. S. (2006). Management of anxiety and depression in adult cancer patients: Toward an evidence-based approach. In A. E. Change, P. A. Ganz, D. F. Hayes, et al. (Eds.), Oncology: An evidence-based approach (pp. 1552–1579). New York: Spriger.Google Scholar
  78. Jacobsson, L. O. (1971). Initial mental disorders in carcinoma of pancreas and stomach. Acta Psychiatric Scand, 220, 120–127.CrossRefGoogle Scholar
  79. Jane, S.-W., Wilkie, D. J., Gallucci, B. B., Beaton, R. D., & Huang, H.-Y. (2009). Effects of a full-body massage on pain intensity, anxiety, and physiological relaxation in Taiwanese patients with metastatic bone pain: A pilot study. Journal of Pain and Symptom Management, 37(4), 754–763.PubMedCrossRefGoogle Scholar
  80. Joffe, R., Rubinow, D., Demicoff, K., Maher, M., & Sindelar, W. F. (1986). Depression and carcinoma of the pancreas. General Hospital Psychiatry, 8, 241–245.PubMedCrossRefGoogle Scholar
  81. Johannsen, M., Farver, I., Beck, N., & Zachariae, R. (2013). The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: A systematic review and meta-analysis. Breast Cancer Research and Treatment, 138(3), 675–690.PubMedCrossRefGoogle Scholar
  82. Kane, R. L., Berstein, L., Wales, J., & Rothenberg, R. (1985). Hospice effectiveness in controlling pain. JAMA, 253(18), 2683–2686.PubMedCrossRefGoogle Scholar
  83. Kangas, M., Henry, J., & Bryant, R. (2005). The course of psychological disorder in the 1st year after cancer diagnosis. Journal of Consulting and Clinical Psychology, 73, 763–768.PubMedCrossRefGoogle Scholar
  84. Katz, M. R., Irish, J. C., & Devins, G. M. (2004). Development and pilot testing of a psychoeducational intervention for oral cancer patients. Psycho-Oncology, 13(9), 642–653.PubMedCrossRefGoogle Scholar
  85. Kaynak, H., Kaynak, D., Gözükırmızı, E., & Guilleminault, C. (2004). The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Medicine, 5(1), 15–20.PubMedCrossRefGoogle Scholar
  86. Kelsen, D. P., Portenoy, R. K., Thaler, H. T., Niedzwiecki, D., Passik, S. D., Tao, Y., et al. (1995). Pain and depression in patients with newly diagnosed pancreas cancer. Journal of Clinical Oncology, 13(3), 748–755.PubMedCrossRefGoogle Scholar
  87. Krebber, A., Buffart, L., Kleijn, G., Riepma, I., Bree, R., Leemans, C., et al. (2014). Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology, 23(2), 121–130.PubMedCrossRefGoogle Scholar
  88. Kroenke, K., Theobald, D., Norton, K., Sanders, R., Schlundt, S., McCalley, S., et al. (2009). The Indiana Cancer Pain and Depression (INCPAD) trial: Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. General Hospital Psychiatry, 31(3), 240–253.  https://doi.org/10.1016/j.genhosppsych.2009.01.007 S0163-8343(09)00014-0 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  89. Kroenke, K., Theobald, D., Wu, J., Norton, K., Morrison, G., Carpenter, J., & Tu, W. (2010). Effect of telecare management on pain and depression in patients with cancer: A randomized trial. JAMA, 304(2), 163–171.  https://doi.org/10.1001/jama.2010.944 304/2/163 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  90. Krouse, R. S. (2010). Gastrointestinal Cancer. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, M. S. Ledoux, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology. New York: Oxford University Press.Google Scholar
  91. Laird, B. J., Boyd, A. C., Colvin, L. A., & Fallon, M. T. (2009). Are cancer pain and depression interdependent? A systematic review. Psychooncology, 18(5), 459–464.  https://doi.org/10.1002/pon.1431.CrossRefPubMedGoogle Scholar
  92. Leon-Pizarro, C., Gich, I., Barthe, E., Rovirosa, A., Farrus, B., Casas, F., et al. (2007). A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psychooncology, 16(11), 971–979.  https://doi.org/10.1002/pon.1171.CrossRefPubMedGoogle Scholar
  93. Leubbert, K., Dahme, B., & Hasenbring, M. (2001). The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: A meta-analytical reivew. Psycho-Oncol, 10, 490–502.CrossRefGoogle Scholar
  94. Levin, T. T., & Alici, Y. (2010). Anxiety disorders. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, M. S. Ledoux, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (pp. 324–331). New York: Oxford University Press.CrossRefGoogle Scholar
  95. Lie, H., Hjermstad, M., Fayers, P., Finset, A., Kaasa, S., Loge, J., & Collaborative, E. P. C. R. (2015). Depression in advanced cancer–assessment challenges and associations with disease load. Journal of Affective Disorders, 173, 176–184.PubMedCrossRefGoogle Scholar
  96. Lin, C. C., Lai, Y. L., & Ward, S. E. (2003). Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. Journal of Pain and Symptom Management, 25(1), 29–37. doi: S0885392402005420 [pii].Google Scholar
  97. Linden, W., & Girgis, A. (2012). Psychological treatment outcomes for cancer patients: What do meta-analyses tell us about distress reduction? Psycho-Oncology, 21(4), 343–350.PubMedCrossRefGoogle Scholar
  98. Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012). Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. Journal of Affective Disorders, 141(2), 343–351.PubMedCrossRefGoogle Scholar
  99. Lovejoy, N. C., & Matteis, M. (1997). Cognitive-behavioral interventions to manage depression in patients with cancer: Research and theoretical initiatives. Cancer Nursing, 20(3), 155–167.PubMedCrossRefGoogle Scholar
  100. Lovell, M. R., Forder, P. M., Stockler, M. R., Butow, P., Briganti, E. M., Chye, R., et al. (2010). A randomized controlled trial of a standardized educational intervention for patients with cancer pain. Journal of Pain and Symptom Management, 40(1), 49–59.  https://doi.org/10.1016/j.jpainsymman.2009.12.013 S0885-3924(10)00309-X [pii].CrossRefPubMedGoogle Scholar
  101. McQuellon, R. P., Wells, M., Hoffman, S., Craven, B., Russell, G., Cruz, J., et al. (1998). Reducing distress in cancer patients with an orientation program. Psycho-Oncol, 7(3), 207–217.CrossRefGoogle Scholar
  102. Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., et al. (2014). Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology, 32(31), 3540–3546.PubMedCrossRefGoogle Scholar
  103. Mehta, R. D., & Roth, A. J. (2015). Psychiatric considerations in the oncology setting. CA: a Cancer Journal for Clinicians, 65(4), 299–314.Google Scholar
  104. Meyer, F., Fletcher, K., Prigerson, H. G., Braun, I. M., & Maciejewski, P. K. (2015). Advanced cancer as a risk for major depressive episodes. Psycho-Oncology, 24(9), 1080–1087.PubMedCrossRefGoogle Scholar
  105. Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: The new frontier in symptom management research. Journal of the National Cancer Institute. Monographs, 32, 17–21.CrossRefGoogle Scholar
  106. Miller, K., & Massie, M. J. (2006). Depression and anxiety. Cancer Journal, 12, 388–397.CrossRefGoogle Scholar
  107. Miller, K., & Massie, M. J. (2010). Depressive disorders. In J. C. Holland (Ed.), Psycho-oncology (pp. 311–318). New York: Oxford University Press.CrossRefGoogle Scholar
  108. Miovic, M., & Block, S. (2007). Psychiatric disorders in advanced cancer. Cancer, 110, 1665–1676.  https://doi.org/10.1002/cncr.22980.CrossRefPubMedGoogle Scholar
  109. Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology, 12(2), 160–174.PubMedCrossRefGoogle Scholar
  110. Montgomery, M., & McCrone, S. H. (2010). Psychological distress associated with the diagnostic phase for suspected breast cancer: Systematic review. Journal of Advanced Nursing, 66(11), 2372–2390.PubMedCrossRefGoogle Scholar
  111. Moorey, S., Cort, E., Kapari, M., Monroe, B., Hansford, P., Mannix, K., et al. (2009). A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychological Medicine, 39(5), 713–723.  https://doi.org/10.1017/S0033291708004169 S0033291708004169 [pii].CrossRefPubMedGoogle Scholar
  112. Moss, E. L., Simpson, J. S. A., Pelletier, G., & Forsyth, P. (2006). An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psycho-Oncology, 15(3), 259–267.PubMedCrossRefGoogle Scholar
  113. Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. The New England Journal of Medicine, 344(13), 961–966.  https://doi.org/10.1056/NEJM200103293441303.CrossRefPubMedGoogle Scholar
  114. Mystakidou, K., Tsilika, E., Parpa, E., Katsouda, E., Galanos, A., & Vlahos, L. (2006). Psychological distress of patients with advanced cancer: Influence and contribution of pain severity and pain interference. Cancer Nursing, 29(5), 400–405. doi: 00002820-200609000-00009 [pii].Google Scholar
  115. National Institute for Clinical Excellence. (2004). Improving supportive and palliative Care for Adults with Cancer. The manual. London: National Institute for Clinical Excellence.Google Scholar
  116. NCCN Clinical practice guidelines in oncology: Distress management. (2017). National Comprehensive Cancer Network.Google Scholar
  117. Newell, S. A., Sanson-Fisher, R. W., & Savolainen, N. J. (2002). Systematic review of psychological therapies for cancer patients: Overview and recommendations for future research. Journal of the National Cancer Institute, 94, 558–584.PubMedCrossRefGoogle Scholar
  118. Okuyama, T., Akechi, T., Mackenzie, L., & Furukawa, T. A. (2017). Psychotherapy for depression among advanced, incurable cancer patients: A systematic review and meta-analysis. Cancer Treatment Reviews.Google Scholar
  119. Oldenmenger, W. H., Geerling, J. I., Mostovaya, I., Vissers, K. C., de Graeff, A., Reyners, A. K., & van der Linden, Y. M. (2018). A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain. Cancer Treatment Reviews, 63, 96–103.  https://doi.org/10.1016/j.ctrv.2017.12.005 PubMedCrossRefGoogle Scholar
  120. Orr, K., & Taylor, D. (2007). Psychostimulants in the treatment of depression: A review of the evidence. CNS Drugs, 21(3), 239–257. doi: 2134 [pii].Google Scholar
  121. Orringer, J. S., Fendrick, A. M., Trask, P. C., Bichakjian, C. K., Schwartz, J. L., Wang, T. S., et al. (2005). The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: A randomized, prospective clinical trial. Journal of the American Academy of Dermatology, 53(2), 224–229.  https://doi.org/10.1016/j.jaad.2005.03.061 S0190962205010959 [pii].CrossRefPubMedGoogle Scholar
  122. Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006). Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: Meta-analyses. International Journal of Psychiatry in Medicine, 36, 13–34.PubMedCrossRefGoogle Scholar
  123. Ostuzzi, G., Benda, L., Costa, E., & Barbui, C. (2015a). Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis. Cancer Treatment Reviews, 41(8), 714–724.PubMedCrossRefGoogle Scholar
  124. Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2015b). Antidepressants for the treatment of depression in people with cancer. The Cochrane Library, 1(6), CD011006.  https://doi.org/10.1002/14651858.CD011006.pub2.
  125. Padilla, G. V., Ferrell, B., Grant, M. M., & Rhiner, M. (1990). Defining the content domain of quality of life for cancer patients with pain. Cancer Nursing, 13(2), 108–115.PubMedCrossRefGoogle Scholar
  126. Paice, J. A., & Ferrell, B. (2011). The management of cancer pain. CA: a Cancer Journal for Clinicians, 61(3), 157–182.Google Scholar
  127. Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., et al. (2004). National Institutes of Health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002. Journal of the National Cancer Institute. Monographs, 32, 9–16.  https://doi.org/10.1093/jncimonographs/djg014 2004/32/9 [pii].CrossRefGoogle Scholar
  128. Pirl, W. F. (2004). Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. Journal of the National Cancer Institute. Monographs, 32, 32–39.CrossRefGoogle Scholar
  129. Portenoy, R. K. (2011). Treatment of cancer pain. The Lancet, 377(9784), 2236–2247.CrossRefGoogle Scholar
  130. Post-White, J., Kinney, M. E., Savik, K., Gau, J. B., Wilcox, C., & Lerner, I. (2003). Therapeutic massage and healing touch improve symptoms in cancer. Integrative Cancer Therapies, 2(4), 332–344.CrossRefGoogle Scholar
  131. Prasertsri, N., Holden, J., Keefe, F. J., & Wilkie, D. J. (2010). Repressive coping style: Relationships with depression, pain, and pain coping strategies in lung cancer out patients. Lung Cancer.  https://doi.org/10.1016/j.lungcan.2010.05.009 S0169-5002(10)00224-2 [pii].PubMedCrossRefGoogle Scholar
  132. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRefGoogle Scholar
  133. Raison, C. L., & Miller, A. H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54(3), 283–294. doi: S000632230300413X [pii].Google Scholar
  134. Ravindran, L. N., & Stein, M. B. (2010). The pharmacologic treatment of anxiety disorders: A review of progress. The Journal of Clinical Psychiatry, 71(7), 839–854.  https://doi.org/10.4088/JCP.10r06218blu.CrossRefPubMedGoogle Scholar
  135. Redd, W. H., Montgomery, G. H., & DuHamel, K. N. (2001). Behavioral intervention for cancer treatment side effects. Journal of the National Cancer Institute, 93, 810–823.PubMedCrossRefGoogle Scholar
  136. Reilly, C. M., Bruner, D. W., Mitchell, S. A., Minasian, L. M., Basch, E., Dueck, A. C., et al. (2013). A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Supportive Care in Cancer, 21(6), 1525–1550.PubMedPubMedCentralCrossRefGoogle Scholar
  137. Riechelmann, R. P., Burman, D., Tannock, I. F., Rodin, G., & Zimmermann, C. (2010). Phase II trial of mirtazapine for cancer-related cachexia and anorexia. American Journal of Hospice and Palliative Medicine®, 27(2), 106–110.CrossRefGoogle Scholar
  138. Rodin, G., Lloyd, N., Katz, M., Green, E., Mackay, J. A., & Wong, R. K. (2007). The treatment of depression in cancer patients: A systematic review. Support Care Cancer, 15(2), 123–136.  https://doi.org/10.1007/s00520-006-0145-3.CrossRefPubMedGoogle Scholar
  139. Roth, A. J., & Massie, M. J. (2007). Anxiety and its management in advanced cancer. Current Opinion in Supportive and Palliative Care, 1, 50–56.  https://doi.org/10.1097/SPC.0b013e32813aeb23 01263393-200704000-00012 [pii].CrossRefPubMedGoogle Scholar
  140. Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J., Goodwin, R. D., Kubzansky, L., et al. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30, 208–225.  https://doi.org/10.1016/j.genhosppsych.2007.12.006 S0163-8343(07)00259-9 [pii].CrossRefPubMedGoogle Scholar
  141. Savard, J., Simard, S., Giguere, I., Ivers, H., Morin, C. M., Maunsell, E., et al. (2006). Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliative & Supportive Care, 4, 219–237.CrossRefGoogle Scholar
  142. Schnoll, R. A., Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Glass, M., et al. (2010). A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes & Control, 21(6), 811–820.CrossRefGoogle Scholar
  143. Sellick, S. M., & Crooks, D. L. (1999). Depression and cancer: An appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psycho-Oncol, 8, 215–333.CrossRefGoogle Scholar
  144. Shakin, E. J., & Holland, J. (1988). Depression and pancreatic cancer. Journal of Pain and Symptom Management, 3(4), 194–198.PubMedCrossRefGoogle Scholar
  145. Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., et al. (2001). Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depression and Anxiety, 13(4), 166–178.PubMedCrossRefGoogle Scholar
  146. Sheard, T., & Maguire, P. (1999). The effect of psychological interventions on anxiety and depression in cancer patients: Results of two meta-analyses. British Journal of Cancer, 80, 1770–1780.PubMedPubMedCentralCrossRefGoogle Scholar
  147. Shennan, C., Payne, S., & Fenlon, D. (2011). What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psycho-Oncology, 20(7), 681–697.PubMedCrossRefGoogle Scholar
  148. Shi, D. D., Yuppa, D. P., Dutton, T., Brais, L. K., Minden, S. L., Braun, I. M., et al. (2017). Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome. Cancer, 123(14), 2735–2742.PubMedCrossRefGoogle Scholar
  149. Simon, S. T., Higginson, I. J., Booth, S., Harding, R., & Bausewein, C. (2010). Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews, 1, CD007354.  https://doi.org/10.1002/14651858.CD007354.pub2.CrossRefGoogle Scholar
  150. Sist, T. C., Florio, G. A., Miner, M. F., Lema, M. J., & Zevon, M. A. (1998). The relationship between depression and pain language in cancer and chronic non-cancer pain patients. Journal of Pain and Symptom Management, 15(6), 350–358. doi: S0885392498000062 [pii].Google Scholar
  151. Smith, A. K., Cenzer, I. S., Knight, S. J., Puntillo, K. A., Widera, E., Williams, B. A., et al. (2010). The epidemiology of pain during the last 2 years of life. Annals of Internal Medicine, 153(9), 563–569.PubMedPubMedCentralCrossRefGoogle Scholar
  152. Smith, P. R., Cope, D., Sherner, T. L., & Walker, D. K. (2014). Update on research-based interventions for anxiety in patients with cancer. Clinical Journal of Oncology Nursing, 18, 5–16.PubMedCrossRefGoogle Scholar
  153. Speca, M., Carlson, L. E., Goodey, E., & Angen, M. (2000). A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosomatic Medicine, 62(5), 613–622.PubMedCrossRefGoogle Scholar
  154. Spencer, R., Nilsson, M., Wright, A., Pirl, W., & Prigerson, H. (2010). Anxiety disorders in advanced cancer patients: Correlates and predictors of end-of-life outcomes. Cancer, 116(7), 1810–1819.  https://doi.org/10.1002/cncr.24954.CrossRefPubMedPubMedCentralGoogle Scholar
  155. Spiegel, D., & Bloom, J. R. (1983). Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosomatic Medicine, 45, 333–339.PubMedCrossRefGoogle Scholar
  156. Spiegel, D., Sands, S., & Koopman, C. (1994). Pain and depression in patients with cancer. Cancer, 74(9), 2570–2578.CrossRefGoogle Scholar
  157. Spielberger, C. D. (1983). Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press.Google Scholar
  158. Stahl, S. M. (2017). Prescriber’s guide: Stahl’s essential psychopharmacology. Cambridge: Cambridge University Press.Google Scholar
  159. Stark, D. P. H., & House, A. (2000). Anxiety in cancer patients. British Journal of Cancer, 83, 1261–1267.PubMedPubMedCentralCrossRefGoogle Scholar
  160. Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., & Selby, P. (2002). Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. Journal of Clinical Oncology, 20, 3137–3148.PubMedCrossRefGoogle Scholar
  161. Steel, J. L., Geller, D. A., Kim, K. H., Butterfield, L. H., Spring, M., Grady, J., et al. (2016). Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer, 122(8), 1270–1282.PubMedPubMedCentralCrossRefGoogle Scholar
  162. Stephenson, N. L., Swanson, M., Dalton, J., Keefe, F. J., & Engelke, M. (2007). Partner-delivered reflexology: Effects on cancer pain and anxiety. Oncology Nursing Forum, 34(1), 127–132.  https://doi.org/10.1188/07.ONF.127-132 K477114620185X62 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  163. Strang, P., & Qvarner, H. (1990). Cancer-related pain and its influence on quality of life. Anticancer Research, 10(1), 109–112.PubMedGoogle Scholar
  164. Teunissen, S. C., de Graeff, A., Voest, E. E., & de Haes, J. C. (2007a). Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliative Medicine, 21(4), 341–346.  https://doi.org/10.1177/0269216307079067 21/4/341 [pii].CrossRefPubMedGoogle Scholar
  165. Teunissen, S. C. C. M., Wesker, W., Kruitwagen, C., de Haes, H. C. J. M., Voest, E. E., & de Graeff, A. (2007b). Symptom prevalence in patients with incurable cancer: A systematic review. Journal of Pain and Symptom Management, 34, 94–104.PubMedCrossRefGoogle Scholar
  166. Thekdi, S. M., Trinidad, A., & Roth, A. (2015). Psychopharmacology in cancer. Current Psychiatry Reports, 17(1), 529.PubMedCrossRefGoogle Scholar
  167. Theobald, D. E., Kirsh, K. L., Holtsclaw, E., Donaghy, K., & Passik, S. D. (2002). An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. Journal of Pain and Symptom Management, 23(5), 442–447.PubMedCrossRefGoogle Scholar
  168. Tickoo, R. S., Key, R. G., & Breitbart, W. S. (2015). Cancer-related pain. In J. C. Holland, W. S. Breitbart, P. N. Butow, P. B. Jacobsen, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (pp. 171–198). New York: Oxford University Press.Google Scholar
  169. Turk, D. C., Sist, T. C., Okifuji, A., Miner, M. F., Florio, G., Harrison, P., et al. (1998). Adaptation to metastatic cancer pain, regional/local cancer pain and non-cancer pain: Role of psychological and behavioral factors. Pain, 74(2–3), 247–256.PubMedCrossRefGoogle Scholar
  170. U.S. Food & Drug Administration. (2016). FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Retrieved February 9, 2018, from https://www.fda.gov/Drugs/DrugSafety/ucm518473.htm
  171. U.S. Food & Drug Administration. (2017, December 15). FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses). Retrieved December 21, 2017, from https://www.fda.gov/Drugs/DrugSafety/ucm297391.htm
  172. Uitterhoeve, R. J., Vernooy, M., Litjens, M., Potting, K., Bensing, J., De Mulder, P., & van Achterberg, T. (2004). Psychosocial interventions for patients with advanced cancer – A systematic review of the literature. British Journal of Cancer, 91, 1050–1062.  https://doi.org/10.1038/sj.bjc.6602103 6602103 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  173. Vahdaninia, M., Omidvari, S., & Montazeri, A. (2009). What do predict anxiety and depression in breast cancer patients? A follow-up study. Social Psychiatry and Psychiatric Epidemiology, 45(3), 355–361.  https://doi.org/10.1007/s00127-009-0068-7.CrossRefPubMedGoogle Scholar
  174. Valentine, A. D. (2003). Cancer pain and depression: Management of the dual-diagnosed patient. Current Pain and Headache Reports, 7(4), 262–269.PubMedCrossRefGoogle Scholar
  175. van den Beuken-van Everdingen, M. H., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Annals of Oncology, 18(9), 1437–1449.  https://doi.org/10.1093/annonc/mdm056 mdm056 [pii].CrossRefGoogle Scholar
  176. van den Beuken-van, M. H., Hochstenbach, L. M., Joosten, E. A., Tjan-Heijnen, V. C., & Janssen, D. J. (2016). Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. Journal of Pain and Symptom Management, 51(6), 1070–1090.e1079.Google Scholar
  177. Vodermaier, A., Linden, W., MacKenzie, R., Greig, D., & Marshall, C. (2011). Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. British Journal of Cancer, 105(12), 1814–1817.PubMedPubMedCentralCrossRefGoogle Scholar
  178. Wang, H.-L., Kroenke, K., Wu, J., Tu, W., Theobald, D., & Rawl, S. M. (2012). Predictors of cancer-related pain improvement over time. Psychosomatic Medicine, 74(6), 642.PubMedPubMedCentralCrossRefGoogle Scholar
  179. Watts, S., Prescott, P., Mason, J., McLeod, N., & Lewith, G. (2015). Depression and anxiety in ovarian cancer: A systematic review and meta-analysis of prevalence rates. BMJ Open, 5(11), e007618.PubMedPubMedCentralCrossRefGoogle Scholar
  180. Wilkinson, S. M., Love, S. B., Westcombe, A. M., Gambles, M. A., Burgess, C. C., Cargill, A., Young, T., Maher, E. J., & Ramirez, A. J. (2007). Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: A multicenter randomized controlled trial. Journal of Clinical Oncology, 25(5), 532–539.Google Scholar
  181. Williams, L. A. (2007). Clinical management of symptom clusters. Sem Onc Nurs, 23, 113–120.CrossRefGoogle Scholar
  182. Williams, S., & Dale, J. (2006). The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. British Journal of Cancer, 94, 372–390.PubMedPubMedCentralCrossRefGoogle Scholar
  183. Wilson, K. G., Chochinov, H. M., Skirko, M. G., Allard, P., Chary, S., Gagnon, P. R., et al. (2007). Depression and anxiety disorders in palliative cancer care. Journal of Pain and Symptom Management, 33(2), 118–129.  https://doi.org/10.1016/j.jpainsymman.2006.07.016 S0885-3924(06)00588-4 [pii].CrossRefPubMedGoogle Scholar
  184. Wilson, K. G., Chochinov, H. M., Allard, P., Chary, S., Gagnon, P. R., Macmillan, K., et al. (2009). Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Research & Management, 14(5), 365–370.CrossRefGoogle Scholar
  185. Wurzman, R., Jonas, W., & Giordano, J. (2008). Chronic pain and depression: A spectrum disorder? The Pain Practitioner, 18(2), 48–54.Google Scholar
  186. Yates, P., Edwards, H., Nash, R., Aranda, S., Purdie, D., Najman, J., et al. (2004). A randomized controlled trial of a nurse-administered educational intervention for improving cancer pain management in ambulatory settings. Patient Education and Counseling, 53, 227–237.PubMedCrossRefGoogle Scholar
  187. Yermal, S. J., Witek-Janusek, L., Peterson, J., & Mathews, H. L. (2010). Perioperative pain, psychological distress, and immune function in men undergoing prostatectomy for cancer of the prostate. Biological Research for Nursing, 11(4), 351–362.PubMedCrossRefGoogle Scholar
  188. Zhang, M.-F., Wen, Y.-S., Liu, W.-Y., Peng, L.-F., Wu, X.-D., & Liu, Q.-W. (2015). Effectiveness of mindfulness-based therapy for reducing anxiety and depression in patients with cancer: A meta-analysis. Medicine, 94(45).Google Scholar
  189. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMedPubMedCentralCrossRefGoogle Scholar
  190. Zimmerman, L., Story, K. T., Gaston-Johansson, F., & Rowles, J. R. (1996). Psychological variables and cancer pain. Cancer Nursing, 19(1), 44–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Lora M. Thompson
    • 1
  • Margarita Bobonis Babilonia
    • 1
  • Sahana Rajasekhara
    • 1
  • Kristine A. Donovan
    • 1
    Email author
  1. 1.Supportive Care Medicine DepartmentH. Lee Moffitt Cancer Center & Research InstituteTampaUSA

Personalised recommendations